PI3K/Akt路径和葡萄糖代谢:癌症中的危险联系
Fabrizio Fontana1, Gaia Giannitti1, Sara Marchesi1
1Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.
International journal of biological sciences
|June 21, 2024
概括
PI3K/Akt通路通过改变细胞代谢来促进癌症的生长,这一过程被称为华堡效应. 了解这些相互作用提供了潜在的新癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 酸丁醇3-酶/蛋白酶B (PI3K/Akt) 途径的异常激活是许多癌症的标志.
- 这一途径对恶性进展和瘤细胞存活至关重要.
- 新出现的证据将PI3K/Akt信号与华堡效应联系起来,一种促进癌细胞有氧糖解的代谢转变.
研究的目的:
- 审查PI3K/Akt信号级联及其关键代谢标之间的复杂相互作用.
- 突出PI3K/Akt在重编程癌细胞代谢中的作用.
- 讨论针对这些相互作用治疗癌症的治疗含义.
主要方法:
- 对研究PI3K/Akt信号在癌症代谢中的研究的文献综述.
- 分析PI3K/Akt影响营养物质转运器和代谢酶的分子机制.
- 检查对各种细胞代谢途径的影响.
主要成果:
- PI3K/Akt可化GLUT1,HK2,PFKB3/4和PKM2等关键酶,驱动有氧糖解.
- 该途径调节转录因子 (MYC,HIF-1α) 和参与代谢重编程的蛋白质 (mTORC1,GSK3,FOXO).
- 这种代谢重编程支持瘤细胞的代谢和合成需求,影响氧化还原稳定和脂质合成.
结论:
- PI3K/Akt通路是癌症新陈代谢的中心调节者,促进了华堡效应.
- 针对PI3K/Akt及其代谢标之间的相互作用,为癌症提供了一个有希望的治疗途径.
- 对这些相互作用的进一步研究可能会导致新的抗癌药物开发.
更多相关视频
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:25cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K